| Dr Sadia Abbasi, MD | |
|
1547 Ohio Ave, Anderson, IN 46016-1917 | |
| (765) 641-7499 | |
| Not Available |
| Full Name | Dr Sadia Abbasi |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1547 Ohio Ave, Anderson, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740570423 | NPI | - | NPPES |
| 201167220 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 01072154A (Indiana) | Primary |
| Entity Name | Indiana University Health Ball Memorial Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455544 PECOS PAC ID: 9537072640 Enrollment ID: O20031110000505 |
News Archive
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.
› Verified 5 days ago
| Entity Name | Meridian Health Services Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992755490 PECOS PAC ID: 5597679845 Enrollment ID: O20031119000531 |
News Archive
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.
› Verified 5 days ago
| Entity Name | Arnett Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164490843 PECOS PAC ID: 0749184380 Enrollment ID: O20031125000119 |
News Archive
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.
› Verified 5 days ago
| Entity Name | Madison County Community Health Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770668030 PECOS PAC ID: 1759291065 Enrollment ID: O20040114000363 |
News Archive
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sadia Abbasi, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Dr Sadia Abbasi, MD 1547 Ohio Ave, Anderson, IN 46016-1917 Ph: (765) 641-7499 |
News Archive
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.
› Verified 5 days ago
Ronald Beahm, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1210 Medical Arts Blvd, Suite 204, Anderson, IN 46011 Phone: 765-298-4530 | |
Dr. Jaime Leigh Stelzer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1629 Medical Arts Blvd, Suite 200, Anderson, IN 46011 Phone: 765-298-5439 Fax: 765-298-4920 | |
Dr. Ramiz Musa Saeed Mohammed, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 1547 Ohio Ave, Anderson, IN 46016 Phone: 765-641-7499 | |
Dr. Teresa Manuella Quant-callender, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1629 Medical Arts Blvd, Suite 200, Anderson, IN 46011 Phone: 765-298-5439 Fax: 765-298-4920 | |
Teri L Schulz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2020 Meridian St Ste 320, Anderson, IN 46016 Phone: 765-646-8727 | |
Scott N Myers, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511 | |
Tony Isiah Mcherron, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1629 Medical Arts Blvd, Suite 200, Anderson, IN 46011 Phone: 765-298-5439 Fax: 765-298-4920 |